Ventricular assist devices (VADs) are mechanical circulatory
devices that are implanted in patients with weakened hearts that cannot pump
enough blood to the rest of the body. They assist the heart in pumping blood
and act as a bridge to transplant for patients awaiting a donor heart or a destination
therapy for patients ineligible for a heart transplant. The growing cases of
heart failure coupled with technological advancements in cardiac assist devices
is driving the adoption of ventricular assist devices. According to the
American Heart Association, around 6.2 million adults in the U.S. suffer from
heart failure and this number is expected to increase 46% by 2030.
The Global
Ventricular Assist Devices Market is estimated to be valued at US$ 3.6 billion
in 2024 and is expected to exhibit a CAGR of 5.3% over the forecast period 2024
To 2031.
Key Takeaways
Key players operating in the Ventricular Assist Devices market are Medtronic,
Abbott Laboratories, Abiomed, Berlin Heart, CardiacAssist, LivaNova, Jarvik
Heart etc.
The rising prevalence of cardiovascular diseases has generated a strong demand
for
Ventricular
Assist Devices Market Trends as a bridge-to-transplant and destination
therapy. The technological advancements introducing portable VADs and
miniaturized VADs is proving beneficial in expanding adoption.
The North America ventricular assist devices market accounted for the largest
revenue share in 2024. However, Asia Pacific region is anticipated witness
highest growth over the forecast period due to increasing healthcare
expenditure, growing awareness and improving access to cardiac care.
Market Drivers
The growing geriatric population and rising incidence of cardiometabolic
disorders are key factors expected to drive the ventricular assist devices
market. Ventricular assist devices offer an improved quality of life and
increased survival rate in late-stage heart failure patients who are not
eligible for heart transplant surgeries. Additionally, favorable reimbursement
for VADs procedures, ongoing research for development of innovative
technologies are further propelling the market growth during forecast period.
PEST Analysis
Political: Regulations around the usage and manufacturing of medical devices
are becoming more stringent globally, requiring extensive compliance.
Economic: Fluctuations in global healthcare spending can impact investment
levels in new medical technologies. However, rising healthcare costs in
developed nations raise demand for technologies that reduce costs.
Social: An aging population fuels the demand for technologies addressing
cardiac issues. Growing awareness about available treatments positively impacts
the market.
Technological: Advancements in materials and miniaturization allow for smaller,
easier to implant devices. Remote monitoring capabilities offer improved
patient management after implantation.
Regions with Highest Market Value
North America accounts for the largest share of the global ventricular assist
devices market in terms of value, owing to favorable reimbursement policies and
high acceptance of advanced technologies. The United States dominates the
regional market.
Fastest Growing Region
Asia Pacific is expected to grow at the fastest pace during the forecast period
due to rising healthcare expenditure, growing incidence of target diseases, and
increasing adoption of advanced treatment options across major countries like
China and India.
Get More
Insights on- Ventricular
Assist Devices Market
For Deeper
Insights, Find the Report in the Language that You want:
About
Author:
Ravina
Pandya, Content
Writer, has a strong foothold in the market research industry. She specializes
in writing well-researched articles from different industries, including food
and beverages, information and technology, healthcare, chemical and materials,
etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment